Niacin use associated with a 34% reduction in cardiovascular events

Posted by .(JavaScript must be enabled to view this email address)
Wednesday, March 09, 2016 5:17 pm Email this article

Niacin use was associated with a 34% reduction in cardiovascular events which was defined as cardiac death, nonfatal myocardial infarction, hospitalization for acute coronary syndrome, stroke, or revascularization procedure according to a review of 11 trials including 9,956 subjects done by researchers at Tufts Medical Center in Boston, Massachusetts, USA.

“The consensus perspective derived from available clinical data supports that niacin reduces [cardiovascular disease] events,” the paper concluded.

Unfortunately, only one study gave niacin alone. The other 10 of the 11 studies gave niacin plus a statin or other cholesterol-lowering drug.

Other articles about niacin

Other articles about niacin are posted here.

Reference

Lavigne PM, and Karas RH. The current state of niacin in cardiovascular disease prevention: a systematic review and meta-regression. J Am Coll Cardiol, 2013 Jan 29; 61(4): 440-446.

Author’s Contact Info

Richard H. Karas, MD, PhD
Molecular Cardiology Research Center
Tufts Medical Center
800 Washington Street, #80
Boston, Massachusetts 02111
.(JavaScript must be enabled to view this email address)

The paper is posted here.

Articles on the same subject can be found here:

• Heart Attack (myocardial infarction)

• Heart Disease

• Niacin (vitamin B3)